Open Access
CC BY-NC-ND 4.0 · World J Nucl Med 2014; 13(03): 209
DOI: 10.4103/1450-1147.144825
Letter to editor

Bone metastases treatment by Sm-153 oxabifore in combination with monoclonal antibody denosumab (Xgeva)

Autor*innen

  • Beuy Joob

    Department of Medical Center, Sanitation 1 Medical Academic Center, Bangkok, Thailand
  • Viroj Wiwanitkit

    1   Department of Tropical Medicine, Joseph Ayo Babalola University, Osun State, Nigeria
Preview Container


Publikationsverlauf

Artikel online veröffentlicht:
23. Mai 2022

© 2014. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India